Retinal pigment epithelium rip with posterior uveitis after intravitreal brolucizumab in neovascular age-related macular degeneration

類似資料

• Brolucizumab in age-related macular neovascularization (BRAIN study): Efficacy, optical coherence tomography biomarkers, and safety profile
  著者:: Supriya Dabir, 等
  出版事項: (2024-01-01)
• Intravitreal Brolucizumab in Patients with Aflibercept-Resistant Neovascular Age-Related Macular Degeneration
  著者:: Ashwin Gupta, 等
  出版事項: (2022-01-01)
• Intravitreal Brolucizumab for Neovascular Age-Related Macular Degeneration in a Vitrectomized Eye
  著者:: Emilia Maggio, 等
  出版事項: (2022-09-01)
• The effect of intravitreal brolucizumab on choroidal thickness in patients with neovascular age-related macular degeneration
  著者:: Ki Woong Bae, 等
  出版事項: (2022-11-01)
• Treatment of neovascular age-related macular degeneration: one year real-life results with intravitreal Brolucizumab
  著者:: Settimio Rossi, 等
  出版事項: (2025-01-01)